Long‐term follow‐up of alpha‐interferon treatment of patients with chronic hepatitis B
Monika van Zonneveld, Pieter Honkoop, Bettina E. Hansen, Hubertus G.M. Niesters, Sarwa Darwish Murad, Robert A. de Man, Solko W. Schalm, Harry L.A. Janssen – 27 February 2004 – Data on the long‐term effects of interferon alfa (IFN) treatment on disease progression and mortality in patients with chronic hepatitis B (CHB) are limited. To evaluate factors that influence clinical outcome and survival, we performed a follow‐up study on 165 hepatitis B e antigen (HBeAg) positive CHB patients treated with IFN between 1978 and 2002.